GlaxoSmithKline (United Kingdom)-ko ikertzaileekin lankidetzan egindako argitalpenak (1)

2005

  1. Inhibition of iNOS activity by 1400W decreases glutamate release and ameliorates stroke outcome after experimental ischemia

    Neurobiology of Disease, Vol. 18, Núm. 2, pp. 375-384